He finally realised that we all know this is a risk stock and he didn’t.
But honestly these guys are basically trying to point out the negative slant and risks on what is clearly known in the marked as a biotech risk stock. Most smaller pre commercial stocks are right….sooooo
It’s is quite the definition of stupidity isn’t it to point out risks to us risk investors on what is an already know as a risk stock…right?
The answer for all posts then should be - It’s ok we know it’s a risk stock, you should find a large commercial big cap stock to comment on.
2024 Here we go again., page-316
-
- There are more pages in this discussion • 628 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |